World & BusinessCity Therapeutics files for an IPO
The drugmaker is seeking more funding for drugs that treat disease by silencing disease-related proteins, Bloomberg reports.
TLDR
Bloomberg reports that Fidelity-backed City Therapeutics has filed for an initial public offering. The company is looking to secure more funding for drugs that treat disease by silencing disease-related proteins.
City Therapeutics files for an IPO
The drugmaker is seeking more funding for drugs that treat disease by silencing disease-related proteins, Bloomberg reports.
TLDR
Bloomberg reports that Fidelity-backed City Therapeutics has filed for an initial public offering. The company is looking to secure more funding for drugs that treat disease by silencing disease-related proteins.